CJC-1295 / Ipamorelin
GHRH + GHS stack — clean, sustained growth hormone release
Where This Comes From
Full traceability from synthesis to your vial. No blind sourcing.
cGMP Synthesis
[cGMP Manufacturer — to be disclosed]
cGMP FacilityIndependent Testing
Analytika ISO Labs Inc. (ISO 17025 Accredited)
ISO 17025 LabBatch Released
Tested October 22, 2024 — all parameters pass.
COA PublishedWhat's in the Vial
Reconstitute CJC-1295 and Ipamorelin separately. Add bacteriostatic water slowly to each vial. Swirl gently — do not shake. Refrigerate at 2–8 °C; use within 28 days. Do not combine in the same vial without physician guidance.
General Protocol Ranges
These are published research ranges — not a prescription. Your physician finalizes your protocol.
The standard research protocol combines CJC-1295 DAC (1–2 mg once weekly) with Ipamorelin (200–300 mcg 2–3 times daily). The combination produces a sustained, pulsatile GH release that more closely resembles physiologic patterns than either compound alone.
Why Physician Oversight?
SourcePeptideCo does not dispense research-grade peptides without licensed physician oversight. This isn't a formality — these compounds interact with individual biochemistry in ways that require clinical judgment.
Our process: you submit a consultation intake, a coordinator matches you with a licensed physician in your state within one business day, and the physician designs a protocol appropriate to your research goals and health profile.
No physician sign-off, no order. That's the standard we hold to.
Request Consultation for CJC-1295 / Ipamorelin →Frequently Asked Questions
CJC-1295 (GHRH analogue) and Ipamorelin (GHS/ghrelin receptor agonist) act on different pituitary receptors and are synergistic when combined. The stack kit ensures you have both compounds from the same batch, tested together, with coordinated dosing guidance from your physician.
DAC (Drug Affinity Complex) is a C-terminal modification that binds CJC-1295 to albumin in circulation, extending its half-life from ~30 minutes to approximately 7–8 days. This allows once-weekly dosing instead of daily injections, which is the primary advantage over unmodified CJC-1295.
Lyophilized peptide powder: store at −20 °C for long-term (up to 24 months) or at 4 °C for up to 6 months. Once reconstituted: refrigerate at 2–8 °C, use within the timeframe specified on your product (typically 14–30 days). Avoid repeated freeze-thaw cycles.
Our lyophilized peptides carry a 24-month expiry from manufacture date as printed on the batch label. Each COA confirms the exact lot date and expiry. Once reconstituted, shelf life drops significantly — see the reconstitution notes for your specific compound.
SourcePeptideCo operates through a licensed physician network. Peptide research compounds can interact with medications, contraindicate with certain conditions, and require clinical judgment for correct dosing. We don't sell without physician oversight — not as a formality, but because the oversight is part of the value.
A Certificate of Analysis (COA) documents the test results for a specific production batch. It certifies identity (the peptide is what we say it is), purity (by HPLC-UV), molecular mass (by LC-MS), endotoxin levels, and sterility. Every batch is tested by an independent ISO 17025-accredited laboratory.